KLK3 and erectile dysfunction: Factors such as age (older), presence of comorbidities, higher prostate-specific antigen (PSA) levels, and worse pretreatment sexual health scores (IIEF score) have been associated with a greater likelihood of developing erectile dysfunction after treatment of prostate cancer.